Bharat Biotech International Limited (BBIL) has conveyed to the government that it has already submitted 90 per cent of documents to WHO for obtaining

AIIMS director Randeep Guleria on Monday said it is better to identify mucormycosis by its name rather than by the colour as labelling the

The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) and Panacea Biotec, one of the leading vaccine and pharmaceutical producers in India, today

Casirivimab and Imdevimab is indicated for restricted use in emergency situation for the treatment of mild to moderate COVID-19 in patients who are

The Pune district administration has directed health officials to screen COVID-19 survivors in rural areas to identify any suspected cases of mucormycosis, or black

Experts in Karnataka will study whether the rise in the Mucormycosis cases is linked to use of industrial oxygen and its possible contamination. Deputy Chief

After black fungus, the Multi-system Inflammatory Syndrome in Children (MIS-C) is the next cause of concern for the medical fraternity to deal with the

Hyderabad based Yashoda Hospitals in their Somajigida unit will start Phase III Trials in association with Natco Pharma who received DCGI approval for conducting

The Andhra Pradesh government on Friday decided to send the Ayurvedic medicine, being touted as a miracle cure for COVID-19 and distributed in SPS

American pharmaceutical company Pfizer and German company BioNTech pledged Friday to deliver 2 billion doses of their COVID-19 vaccine to middle- and low-income countries